The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome


CARLIOGLU A., Kaygusuz I., Karakurt F., Gumus I. I., UYSAL A., Kasapoglu B., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.290, no.5, pp.929-935, 2014 (SCI-Expanded, Scopus)

Abstract

Purpose To evaluate the platelet activating factor acetyl hydrolyze (PAF-AH), oxidized low-density lipoprotein (ox-LDL), paraoxonase 1 (PON1), arylesterase (ARE) levels and the effects of metformin and Diane-35 (ethinyl oestradiol + cyproterone acetate) therapies on these parameters and to determine the PON1 polymorphisms among PCOS patients.